Immortalized retinal pigmentary epithelial cell lines and their applications
AssigneeNeurotech S.A.
InventorsJohn Greenwood, Peter Adamson, Raymond Lund
Life of this patent
Estimating the term…
Loading patent…
AssigneeNeurotech S.A.
InventorsJohn Greenwood, Peter Adamson, Raymond Lund
Estimating the term…
The invention features immortalized retina-derived (retinal endothelial or retinal epithelial pigmentary) cell lines capable of being implanted in the retina and of carrying a therapeutic substance to the eye and to the central nervous system. Such lines can also be used as a model for studying blood central nervous system interfaces. These lines are derived from primary retinal cultures selected from the group consisting of primary retinal endothelial cells and primary retinal epithelial cells, comprise a nucleic acid fragment containing at least one immortalizing fragment of a heat-sensitive viral oncogene, which nucleic fragment is optionally associated with at least one selection gene, and have the morphological characteristics and at least the expression characteristics of the surface antigens of corresponding primary cultures.
An injectable, stable, immortalized, non-tumorigenic PVG rat retinal pigmenty epithelial cell line,
A method for treating primary or secondary ophthalmological or neurological disorders, comprising non-tumorigenically grafting cells of the rat retinal pigmentary epithelial cell line into the eye of a mammalian host,
A method for making a non-tumorigenic rat retinal pigmentary epithelial cell line, comprising:
Dependencies are inferred from the claim text.